MSD - Product Table

Committed to bringing out the best in medicine

Healthcare Professionals

Products Available in the UK

World Leading Portfolio

Products in our portfolio include treatments for asthma, cardiovascular problems, emesis, glaucoma, gout, hair loss, HIV/AIDS, benign prostatic hyperplasia, infection, migraine, osteoarthritis, osteoporosis and arthritis.

Brand name	Generic name	Therapy area
ARCOXIA®	etoricoxib	Arthritis
AGGRASTAT®	tirofiban	Cardiovascular
COSOPT®	dorzolamide plus timolol	Ophthalmology
COZAAR®	losartan	Blood Pressure
COZAAR-Comp®	losartan plus hydrochlorothiazide	Blood Pressure
CRIXIVAN®	indinavir	HIV
EZETROL®	ezetimibe	Hypercholesterolaemia
FOSAMAX®	alendronate	Osteoporosis
FOSAVANCE®	alendronate	Osteoporosis
FOSAMAX ONCE-WEEKLY®	alendronate	Osteoporosis
JANUVIA®	sitagliptan	Type 2 Diabetes
INEGY®	ezetimibe plus simvastatin	Hypercholesterolaemia
INEGY®	ezetimibe plus simvastatin	Hypercholesterolaemia
MAXALT®	rizatriptan	Migraine
PRIMAXIN® IM Injection	imipenum plus cilastatin	Infection
PRIMAXIN® IV Injection	imipenum plus cilastatin	Infection
PROPECIA®	finasteride	Hair loss
PROSCAR®	finasteride	Urology
SINGULAIR®	montelukast	Asthma
TIMOPTOL®	timolol	Ophthalmology
TRUSOPT®	dorzolamide	Ophthalmology

RESEARCH

It costs about £550 million over 12 years to bring one medicine from discovery in a laboratory to the patient.

This site is intended for residents of the United Kingdom. Merck Sharp & Dohme Limited, registered in England No 820771